Mesoblast Limited (MESO)
Nasdaq: MESO · Biological Products, (No Diagnostic Substances) · Melbourne, Victoria, AU · filing with the SEC since 2005
Who runs Mesoblast Limited
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Itescu Silviu
CEO and Managing Director. First filing Apr 2026, latest Apr 1, 2026, 0 filings in all.
Officers reporting now
3
of 9 people with a filing in the last fifteen months
Directors reporting now
6
9 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Obrien James Michael | Chief Financial Officer | Mar 2026 | Jul 9, 2026 | none |
| Itescu Silviu | CEO and Managing Director | Apr 2026 | Apr 1, 2026 | none |
| Rose Eric Allen | Chief Medical Officer,Director | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Cobley Lynette Elizabeth | director | Apr 2026 | Apr 29, 2026 | none |
| George Gregory | director | Mar 2026 | Apr 13, 2026 | none |
| Burns William Murray | director | Apr 2026 | Apr 1, 2026 | none |
| Bell Jane Catherine | director | Mar 2026 | Mar 18, 2026 | none |
| Facchina Philip James | director | Mar 2026 | Mar 18, 2026 | none |
| Krause Philip R. | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.